OakChart

Kardigan Inc

KARDHealthcare·Biotechnology·USA·Small·NASD·Nov 11 • 3:59 PM ET

15.68+0.50 (3.29%)
2026-11-12 02:37 CET
Market cap
1,419.39 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-116.24 USD m
Free cash flow, TTM
-51.48 USD m
EPS diluted, TTM
-1.24
P/E
-
Compare

Price

KARD against its 20 and 50-day averages
2050miss
15.0020.0025.003.3M6.6MVolumeJun 26Jul 26Aug 26Sep 26Oct 26Nov 26KARDclose 15.6820-day 13.9850-day 15.4415.6852w high52w low

41.9% under the 52-week high of 27.00 on 29 Jun 2026. 52-week low 12.23 on 7 Oct 2026. Last 15 sessions, 34.5% high to low

Volume 0.74× normal · the line is the 50-bar volume average

Profile

KARD
52-week range, 23% of the way up
12.2327.00

Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its "Cardiac Intelligence" platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.

IndexRUT
Employees210
IPOJun 18, 2026
ATR, 14d1.26
Rel volume0.74
Short float8.91%
Insider own31.67%
Inst own63.78%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.47B
Enterprise Value881.89M
Income-
Sales-
Book/sh6.59
Cash/sh6.39
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees210
IPOJun 18, 2026

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B2.38
P/C2.45
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio8.72
Current Ratio8.72
Debt/Eq0.02
LT Debt/Eq0.02
Option/ShortYes / Yes

Earnings

EPS (ttm)-
EPS next Y-
EPS next Q-0.78
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y- -
EPS Y/Y TTM-
Sales Y/Y TTM-
EPS Q/Q-
Sales Q/Q-
EarningsAug 11 BMO
EPS/Sales Surpr.-582.66% -

Ownership

Insider Own31.67%
Insider Trans23.45%
Inst Own63.78%
Inst Trans117.19%
ROA-
ROE-
ROIC-
Gross Margin-
Oper. Margin-
Profit Margin-
SMA2012.14%
SMA501.57%
SMA200-15.98%
Trades-

Technical

Shs Outstand93.47M
Shs Float63.89M
Short Float8.91%
Short Ratio9.72
Short Interest5.69M
52W High27.00 -41.93%
52W Low12.23 28.21%
Volatility10.69% 8.49%
ATR (14)1.26
RSI (14)56.86
Beta-
Rel Volume0.74
Avg Volume585.55K
Volume432,187

Performance

Perf Week0.77%
Perf Month20.89%
Perf Quarter-28.11%
Perf Half Y-
Perf YTD-3.51%
Perf Year-
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom1.11
Target Price41.12
Prev Close15.18
Price15.68
Change %3.29%

Analyst ratings

latest 9 of 9
DateActionAnalystRating changeTargetImplied
Nov 04, 2026InitiatedHH.C. WainwrightBuy$42+167.9%
Oct 29, 2026InitiatedCCantor FitzgeraldOverweight$50+218.9%
Oct 22, 2026InitiatedRRobert W. BairdOutperform$43+174.2%
Oct 16, 2026InitiatedWWilliam BlairOutperform
Oct 12, 2026InitiatedUUBSBuy$25+59.4%
Jul 13, 2026InitiatedTTD CowenBuy$46+193.4%
Jul 13, 2026InitiatedLLeerink PartnersOutperform$37+136.0%
Jul 13, 2026InitiatedJJP MorganOverweight$51+225.3%
Jul 13, 2026InitiatedJJefferiesBuy$40+155.1%

Peers

Mkt cap
TickerCompanyMkt cap
CYTKCytokinetics Inc8.15B
EWTXEdgewise Therapeutics Inc5.21B
LXEOLexeo Therapeutics Inc252.01M
TNYATenaya Therapeutics Inc84.61M
MLYSMineralys Therapeutics Inc1.43B
TECXTectonic Therapeutic Inc438.06M
RCKTRocket Pharmaceuticals Inc272.24M
BBIOBridgeBio Pharma Inc15.49B
MISTMilestone Pharmaceuticals Inc82.44M
BMYBristol-Myers Squibb Co128.59B

Insider trading

3 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
HRTG GPE, LLC10% OwnerJun 22 '26Buy16.003,125,00050,000,00014,866,868Jun 24 09:26 PM
BERNS PAUL LDirectorJun 22 '26Buy16.001,250,00020,000,00015,042,035Jun 24 04:20 PM
ARCH Venture Partners XIII, LLDirectorJun 22 '26Buy16.001,250,00020,000,00015,042,035Jun 24 04:18 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
ONEQFidelity Nasdaq Composite Index ETFAUM: 10.35B
VTWGVanguard Russell 2000 Growth Index ETFAUM: 1.41B
SCHBSchwab U.S. Broad Market ETFAUM: 44.09B

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-08-11-4.610-0.675-4.6120.000.004
2026Q12026-06-03-2.048--0.6280.00--
2026Q3---0.780--0.009
2026Q4---0.729--0.339
2027Q1---0.943--0.006
2027Q2---0.967--0.006
2027Q3---0.970--0.006
2027Q4---0.978--0.006
2028Q1---1.020---1
2028Q2---0.990---1
2028Q3---0.950---1
2028Q4---0.910---1

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-11-036000.000.000.00
2026Q3S2026-10-285000.000.000.00
2026Q3S2026-10-144000.000.000.00
2026Q3S2026-10-093000.000.000.00
2026Q3S2026-08-112000.000.000.00
2026Q3S2026-07-102000.000.000.00
2026Q3R2026-11-07410-0.75-0.85-0.63
2026Q3R2026-10-28411-0.75-0.85-0.63
2026Q3R2026-10-20311-0.72-0.80-0.63
2026Q3R2026-10-14301-1.45-2.82-0.74
2026Q3R2026-10-09201-0.77-0.80-0.74
2026Q3R2026-08-24101-0.80-0.80-0.80
2026Q3R2026-08-11100-0.71-0.71-0.71
2026Q3R2026-07-10100-0.71-0.71-0.71

Estimate history

EPS, annual-0.992-2.148
Period20242025
EPS, quarterly-0.202-0.643-0.628-1.244
PeriodQ1 '25Q2 '25Q1 '26Q2 '26
Sales, annual00
Period20242025
Sales, quarterly0000
PeriodQ1 '25Q2 '25Q1 '26Q2 '26
Shares, annual89.33989.33993.468
Period20242025MRQ
Shares, quarterly89.33989.33989.33993.468
PeriodQ1 '25Q2 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY
Total Revenue0.000.000.00
Cost of Goods Sold Incl. D&A2.195.740.36
Gross Profit-2.19-5.74-0.36
Selling, General and Administrative Excl. Other73.04196.8696.30
Research and Development55.23149.8984.29
Other Operating Expense0.000.000.00
Operating Income-75.23-202.60-96.66
Interest Expense0.000.00-
Unusual Expense43.535.49-6.75
Net Income Before Taxes-116.24-196.45-88.66
Income Taxes0.00-4.510.00
Consolidated Net Income-116.24-191.94-88.66
Net Income From Continuing Operations-116.24-191.94-88.66
Net Income-116.24-191.94-88.66
EPS (Recurring)-0.92-2.11-1.05
EPS (Basic, Before Extraordinaries)-1.24-2.15-0.99
EPS (Diluted)-1.24-2.15-0.99
EBITDA-73.04-196.86-96.30
Non-Operating Income (Expense)2.5211.641.25
Other After Tax Adjustments0.000.000.00
Stock Option Compensation Expense11.7023.875.95
Shares Outstanding93.4789.3489.34
Market Capitalization1,419.391,419.39-

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q22025Q1
Total Revenue0.000.000.000.00
Cost of Goods Sold Incl. D&A2.192.111.480.76
Gross Profit-2.19-2.11-1.48-0.76
Selling, General and Administrative Excl. Other73.0456.6055.6425.32
Research and Development55.2343.8834.8118.47
Other Operating Expense0.000.000.000.00
Operating Income-75.23-58.71-57.12-26.08
Interest Expense0.000.000.000.00
Unusual Expense43.530.001.342.57
Net Income Before Taxes-116.24-56.07-57.45-22.19
Income Taxes0.000.000.00-4.17
Consolidated Net Income-116.24-56.07-57.45-18.02
Net Income From Continuing Operations-116.24-56.07-57.45-18.02
Net Income-116.24-56.07-57.45-18.02
EPS (Recurring)-0.92-0.63-0.63-0.18
EPS (Basic, Before Extraordinaries)-1.24-0.63-0.64-0.20
EPS (Diluted)-1.24-0.63-0.64-0.20
EBITDA-73.04-56.60-55.64-25.32
Non-Operating Income (Expense)2.522.641.026.46
Other After Tax Adjustments0.000.000.000.00
Stock Option Compensation Expense11.705.3618.652.32
Shares Outstanding93.4789.3489.3489.34
Market Capitalization1,419.392,270.72--

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY
Cash & Short Term Investments335.4949.40
Short Term Receivables0.000.00
Inventories0.000.00
Other Current Assets9.870.92
Total Current Assets345.3550.32
Net Property, Plant & Equipment18.2311.13
Total Investments and Advances0.542.08
Intangible Assets23.230.00
Deferred Tax Assets7.441.93
Other Assets3.590.00
Total Assets398.3865.45
Short Term Debt Incl. Current Port. of LT Debt3.140.78
Accounts Payable7.993.86
Other Current Liabilities26.403.64
Total Current Liabilities37.548.29
Long Term Debt10.6916.05
Provision for Risks Charges0.000.00
Deferred Tax Liabilities7.441.93
Other Liabilities6.902.37
Total Liabilities62.5628.62
Non-Equity Reserves0.000.00
Preferred Stock - Carrying Value586.15120.02
Common Equity-250.34-83.19
Total Shareholders Equity335.8136.83
Accumulated Minority Interest0.000.00
Total Equity335.8136.83
Total Liabilities & Stockholders Equity398.3865.45
Book Value Per Share-2.80-0.93
Tangible Book Value Per Share-3.06-0.93
Full-Time Employees210-
Price to Book Ratio2.31-
Return on Assets-82.76-
Return on Equity-103.02-
Return on Invested Capital-55.39-167.67
Quick Ratio9.206.07
Current Ratio9.206.07

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY
Net Income-116.24-191.94-88.66
Depreciation2.195.740.36
Other Funds (Non Cash)55.7733.2364.62
Funds from Operations-58.27-157.48-23.68
Extraordinary Item0.000.000.00
Changes in Working Capital7.726.434.85
Cash from Operating Activities-50.55-151.06-18.82
Capital Expenditures-2.27-5.14-1.80
Net Assets From Acquisitions0.00-3.960.00
Sale of Fixed Assets and Businesses0.000.000.00
Purchase or Sale of Investments-71.64-226.440.00
Purchase of Investments-177.51-243.440.00
Sale Or Maturity of Investments105.8817.000.00
Other Uses0.00-1.50-34.62
Other Sources0.000.000.00
Cash from Investing Activities-73.90-237.04-36.42
Cash Dividends Paid0.000.000.00
Preferred Dividends (Cash Flow)0.000.000.00
Change in Capital Stock428.61454.17105.01
Repurchase of Common Pref Stock0.000.000.00
Sale of Common Pref Stock428.61454.17105.01
Proceedsfrom Stock Options427.80453.61102.64
Issuance or Reduction of Debt, Net0.000.000.00
Change in Long Term Debt0.000.000.00
Issuance of Long Term Debt0.000.000.00
Reduction of Long Term Debt0.000.000.00
Net Financing Active Other Cash Flow-1.69-6.360.00
Other Financing Activities Uses-1.69-6.360.00
Cash from Financing Activities426.91447.81105.01
Net Change in Cash302.4659.7149.77
Free Cash Flow-51.48-156.13-20.63
Deferred Taxes & Investment Tax Credit--4.510.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q22025Q1
Cash & Short Term Investments597.60287.11--
Short Term Receivables0.000.00--
Inventories0.000.00--
Other Current Assets12.5711.03--
Total Current Assets610.16298.13--
Net Property, Plant & Equipment18.7919.28--
Total Investments and Advances63.640.54--
Intangible Assets26.4226.19--
Other Assets2.784.04--
Total Assets721.79348.19--
Short Term Debt Incl. Current Port. of LT Debt3.753.66--
Accounts Payable14.029.15--
Other Current Liabilities52.2318.85--
Total Current Liabilities70.0031.66--
Long Term Debt9.6010.25--
Provision for Risks Charges0.000.00--
Other Liabilities26.679.35--
Total Liabilities106.2651.27--
Non-Equity Reserves0.000.00--
Preferred Stock - Carrying Value0.00597.55--
Common Equity615.52-300.63--
Total Shareholders Equity615.52296.92--
Accumulated Minority Interest0.000.00--
Total Equity615.52296.92--
Total Liabilities & Stockholders Equity721.79348.19--
Book Value Per Share6.59-3.37--
Tangible Book Value Per Share6.30-3.66--
Full-Time Employees-241--
Price to Book Ratio2.31-7.55--
Return on Invested Capital-18.59-18.25--
Quick Ratio8.729.42--
Current Ratio8.729.42--

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q22025Q1
Net Income-116.24-56.07-57.45-18.02
Depreciation2.192.111.480.76
Other Funds (Non Cash)55.771.7919.990.28
Funds from Operations-58.27-52.17-35.97-21.15
Extraordinary Item0.000.000.000.00
Changes in Working Capital7.72-4.604.60-0.25
Cash from Operating Activities-50.55-56.78-31.38-21.40
Capital Expenditures-2.27-2.63-2.06-0.54
Net Assets From Acquisitions0.000.000.00-3.96
Sale of Fixed Assets and Businesses0.000.000.000.00
Purchase or Sale of Investments-71.6421.640.000.00
Purchase of Investments-177.51-57.700.000.00
Sale Or Maturity of Investments105.8879.350.000.00
Other Uses0.000.000.000.00
Other Sources0.000.000.000.00
Cash from Investing Activities-73.9019.01-2.06-4.50
Cash Dividends Paid0.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.00
Change in Capital Stock428.6110.420.18100.00
Repurchase of Common Pref Stock0.000.000.000.00
Sale of Common Pref Stock428.6110.420.18100.00
Proceedsfrom Stock Options427.8010.000.00100.00
Issuance or Reduction of Debt, Net0.000.000.000.00
Change in Long Term Debt0.000.000.000.00
Issuance of Long Term Debt0.000.000.000.00
Reduction of Long Term Debt0.000.000.000.00
Net Financing Active Other Cash Flow-1.69-0.100.000.00
Other Financing Activities Uses-1.69-0.100.000.00
Cash from Financing Activities426.9110.320.18100.00
Net Change in Cash302.46-27.44-33.2574.10
Free Cash Flow-51.48-57.94-33.39-21.94

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-308.91%5.7M63.9M550.44K
2026-10-158.30%5.3M63.9M502.97K
2026-09-306.96%4.4M63.9M458.40K
2026-09-154.02%2.6M63.9M448.95K
2026-08-313.46%2.2M63.8M455.71K
2026-08-143.04%1.9M63.8M513.67K
2026-07-312.54%1.6M62.2M614.67K
2026-07-152.68%1.7M62.2M864.33K
2026-06-30-1.5M-1.39M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5010.9015.500.000.0000.000.000.993-0.0170.001
call5.008.4012.900.0012.1560.000.000.938-0.1390.003
call7.505.7010.500.008.5100.000.000.900-0.1370.004
call10.003.208.000.006.1010.000.000.851-0.1260.006
call12.500.805.500.004.3140.000.000.778-0.1080.007
call15.000.002.001.501.61322.000.000.672-0.2400.009
call17.500.050.500.401.14835.000.000.304-0.0560.009
call20.000.004.900.002.4270.000.000.316-0.1160.009
call22.500.004.900.002.2310.000.000.194-0.0850.007
call25.000.004.900.002.6000.000.000.174-0.0920.006
call30.000.004.900.003.1680.000.000.150-0.1030.006
put2.500.002.300.056.0081.000.00-0.007-0.0170.001
put5.000.004.900.000.0000.000.00-0.057-0.2010.003
put7.500.004.900.0014.9450.000.00-0.069-0.2640.003
put10.000.004.900.1510.4770.000.00-0.138-0.3080.005
put12.500.002.100.352.5962610.00-0.222-0.1060.007
put15.000.004.900.505.68750.000.00-0.337-0.2300.009
put17.500.305.000.003.9870.000.00-0.696-0.0550.009
put20.002.006.700.003.8760.000.00-0.772-0.0720.007
put22.504.509.200.004.2260.000.00-0.806-0.0820.007
put25.007.0011.700.004.6870.000.00-0.826-0.0900.006
put30.0012.0016.600.005.4230.000.00-0.850-0.1010.006

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-068-KCurrent report2026-11-06SEC
2026-10-014Statement of changes in beneficial ownership of securities2026-09-29SEC
2026-10-013Initial statement of beneficial ownership of securities2026-09-29SEC
2026-10-01SCHEDULE 13D/ASEC
2026-09-308-KCurrent report2026-09-29SEC
2026-08-13SCHEDULE 13GSEC
2026-08-13SCHEDULE 13GSEC
2026-08-1110-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-118-KCurrent report2026-08-11SEC
2026-08-07SCHEDULE 13G/ASEC
2026-08-06SCHEDULE 13GSEC
2026-07-134Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-29SCHEDULE 13GSEC
2026-06-29SCHEDULE 13DSEC
2026-06-25SCHEDULE 13DSEC
2026-06-244Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-243/A2026-06-17SEC
2026-06-244Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-244Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-238-KCurrent report2026-06-22SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-0690.00M300
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
HRTG GPE, LLC19.30%
FMR LLC10.48%
PERCEPTIVE ADVISORS LLC9.35%
T. Rowe Price Investment Management, Inc.4.80%
Capital Research Global Investors4.10%
JPMORGAN CHASE & CO2.04%
ALLIANCEBERNSTEIN L.P.1.75%
Liberty Mutual Group Asset Management Inc.1.36%
JENNISON ASSOCIATES LLC1.03%
Paradigm Biocapital Advisors LP1.03%

Funds

Fund% owned
SMALLCAP World Fund Inc4.00%
Fidelity Contrafund1.35%
JPMorgan Small Cap Growth Fund0.94%
AB Small Cap Growth Portfolio0.85%
T. Rowe Price Small-Cap Stock Fund, Inc.0.84%
T. Rowe Price Small-Cap Value Fund, Inc.0.72%
Fidelity Growth Company Fund0.69%
Eventide Healthcare & Life Sciences Fund0.68%
T. Rowe Price New Horizons Fund, Inc.0.51%
MFS New Discovery Fund0.51%

OakChart. KARD. Cached 15 minutes.

Some panels did not load: news.